
"Gilead Sciences has applied seeking marketing authorisation for its anti-viral drug remdesivir to India's Central Drugs Standard Control Organisation (CDSCO). The CDSCO will examine the application with the help of the expert committee. It will take a final decision based on the recommendations of the expert committee," a source said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ApxrI1
via
IFTTT
0 comments:
Post a Comment